|
G |
Abhd11-as1 |
ABHD11 antisense RNA 1 (tail to tail) |
increases expression |
ISO |
Propofol results in increased expression of BICDL3P mRNA |
CTD |
PMID:35238236 |
|
NCBI chr12:21,681,118...21,682,106
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
multiple interactions |
EXP |
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]] |
CTD |
PMID:24810525 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation decreases phosphorylation |
EXP ISO |
Propofol promotes the reaction [Streptozocin results in decreased phosphorylation of AKT1 protein] Propofol results in increased phosphorylation of AKT1 protein Propofol results in decreased phosphorylation of AKT1 protein CASC9 protein inhibits the reaction [Propofol results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:24810525 PMID:35238236 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
decreases expression multiple interactions |
EXP |
Propofol results in decreased expression of APAF1 protein Propofol inhibits the reaction [Doxorubicin results in increased expression of APAF1 protein] |
CTD |
PMID:21468576 PMID:22015447 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
multiple interactions decreases expression |
EXP |
Bicuculline inhibits the reaction [Propofol results in decreased expression of ARC protein] |
CTD |
PMID:18946287 |
|
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
|
|
G |
Avp |
arginine vasopressin |
multiple interactions |
ISO |
[Propofol co-treated with desflurane] results in increased expression of AVP protein |
CTD |
PMID:8017643 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression decreases expression |
EXP ISO |
[Resveratrol co-treated with Propofol] results in decreased expression of BAX; NUFIP1 protein affects the reaction [Propofol results in increased expression of BAX protein]; PEA15 protein inhibits the reaction [Propofol results in increased expression of BAX protein]; Propofol inhibits the reaction [Doxorubicin results in increased expression of BAX protein] Propofol results in decreased expression of BAX [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BAX protein; Acetylcysteine inhibits the reaction [Propofol results in increased expression of BAX protein] |
CTD |
PMID:21786383 PMID:22015447 PMID:23353162 PMID:28804952 PMID:31257496 PMID:38599287 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions decreases expression |
EXP ISO |
Propofol results in increased expression of BCL2; Propofol results in increased expression of BCL2 mRNA; Propofol results in increased expression of BCL2 protein [Resveratrol co-treated with Propofol] results in increased expression of BCL2; NUFIP1 protein affects the reaction [Propofol results in decreased expression of BCL2 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of BCL2 protein]; Propofol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; Propofol inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]; Wortmannin inhibits the reaction [Propofol results in increased expression of BCL2 protein] [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BCL2 protein; Acetylcysteine inhibits the reaction [Propofol results in decreased expression of BCL2 protein] |
CTD |
PMID:19703415 PMID:21786383 PMID:22015447 PMID:23353162 PMID:24810525 PMID:28804952 PMID:31257496 PMID:38599287 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
EXP |
Propofol results in decreased expression of BCL2L1 mRNA; Propofol results in decreased expression of BCL2L1 protein |
CTD |
PMID:26254736 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Blacat1 |
BLACAT1 overlapping LEMD1 locus |
increases expression |
ISO |
Propofol results in increased expression of BLACAT1 mRNA |
CTD |
PMID:35238236 |
|
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
multiple interactions |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 protein] |
CTD |
PMID:21307008 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
C17h10orf67 |
similar to human chromosome 10 open reading frame 67 |
increases expression |
ISO |
Propofol results in increased expression of C10ORF67 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr17:82,062,461...82,174,401
Ensembl chr17:82,071,838...82,174,353
|
|
G |
C1h10orf143 |
similar to human chromosome 10 open reading frame 143 |
decreases expression |
ISO |
Propofol results in decreased expression of C10ORF143 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 1:192,184,440...192,222,676
Ensembl chr 1:192,184,445...192,222,398
|
|
G |
C3 |
complement C3 |
multiple interactions |
ISO |
[Triglycerides co-treated with Propofol] results in increased expression of C3 protein modified form |
CTD |
PMID:15983144 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
affects response to substance |
EXP |
CACNA1I protein affects the susceptibility to Propofol |
CTD |
PMID:15644869 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases activity |
ISO |
Propofol analog results in decreased activity of CA1 protein; Propofol results in decreased activity of CA1 protein |
CTD |
PMID:19231207 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases activity |
ISO |
Propofol analog results in decreased activity of CA2 protein; Propofol results in decreased activity of CA2 protein |
CTD |
PMID:19231207 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car5a |
carbonic anhydrase 5A |
decreases expression |
ISO |
Propofol results in decreased expression of CA5A mRNA |
CTD |
PMID:35238236 |
|
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity decreases expression increases expression increases cleavage |
EXP ISO |
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole promotes the reaction [Propofol results in increased cleavage of CASP3 protein]; [Resveratrol co-treated with Propofol] results in decreased expression of CASP3; calpeptin inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; hyperforin inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; NUFIP1 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; Propofol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Propofol inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]] Propofol results in increased activity of CASP3 protein Propofol results in decreased expression of CASP3; Propofol results in decreased expression of CASP3 protein Propofol results in increased expression of CASP3 protein modified form Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP3 protein] |
CTD |
PMID:17640472 PMID:21786383 PMID:22015447 PMID:23353162 PMID:24810525 PMID:26254736 PMID:28804952 PMID:31257496 PMID:36640868 PMID:38599287 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
decreases cleavage increases activity increases cleavage multiple interactions |
EXP ISO |
Propofol results in decreased cleavage of CASP9 protein Propofol results in increased activity of CASP9 protein Propofol results in increased cleavage of CASP9 protein Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP9 protein] |
CTD |
PMID:21468576 PMID:21786383 PMID:28804952 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression multiple interactions decreases activity |
ISO EXP |
Propofol results in increased expression of CAT protein Acetylcysteine inhibits the reaction [Propofol results in decreased activity of CAT protein] |
CTD |
PMID:16938161 PMID:21468576 PMID:28804952 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccdc196 |
coiled-coil domain containing 196 |
affects expression |
ISO |
Propofol affects the expression of CCDC196 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 6:96,913,960...96,939,415
Ensembl chr 6:96,915,869...96,931,141
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Propofol results in decreased expression of CCNB1 protein |
CTD |
PMID:28804952 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
Propofol results in increased expression of CCND1 protein |
CTD |
PMID:28804952 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd68 |
Cd68 molecule |
increases expression multiple interactions |
ISO |
Propofol results in increased expression of CD68 mRNA Lipopolysaccharides inhibits the reaction [Propofol results in increased expression of CD68 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
Propofol affects the reaction [LINC01133 affects the expression of CDH1 protein] |
CTD |
PMID:38146619 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh11 |
cadherin 11 |
multiple interactions |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in decreased expression of CDH11 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
Propofol affects the reaction [LINC01133 affects the expression of CDH2 protein] |
CTD |
PMID:38146619 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression multiple interactions |
ISO |
Propofol results in decreased expression of CDK1 protein [Propofol results in increased susceptibility to STA 9090] which results in decreased expression of CDK1 protein |
CTD |
PMID:24784839 PMID:28804952 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
multiple interactions increases expression |
EXP |
Dexmedetomidine inhibits the reaction [Propofol results in increased expression of CDK5R1 protein] |
CTD |
PMID:31187143 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
multiple interactions |
EXP |
Propofol inhibits the reaction [Acetylcholine results in increased activity of CHRM1 protein]; Propofol inhibits the reaction [Scopolamine Derivatives results in increased activity of CHRM1 protein] |
CTD |
PMID:14534362 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases phosphorylation multiple interactions |
EXP |
Propofol results in decreased phosphorylation of CREB1 protein PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:31257496 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
Propofol results in decreased expression of CXCL12 protein |
CTD |
PMID:36207479 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA] |
CTD |
PMID:21307008 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
ISO |
Propofol results in decreased expression of CXCR4 protein |
CTD |
PMID:36207479 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
Propofol results in increased expression of CYCS protein |
CTD |
PMID:21786383 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases metabolic processing |
ISO |
CYP2B6 protein results in increased metabolism of Propofol |
CTD |
PMID:15769884 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Dio3os |
DIO3 opposite strand upstream RNA |
decreases expression |
ISO |
Propofol results in decreased expression of DIO3OS mRNA |
CTD |
PMID:35238236 |
|
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
increases expression multiple interactions |
EXP |
Propofol results in increased expression of DLG4 protein NUFIP1 protein affects the reaction [Propofol results in increased expression of DLG4 protein] |
CTD |
PMID:38599287 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases phosphorylation multiple interactions |
EXP |
Propofol results in increased phosphorylation of DPYSL2 protein Dexmedetomidine inhibits the reaction [Propofol results in increased phosphorylation of DPYSL2 protein] |
CTD |
PMID:31187143 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Edn1 |
endothelin 1 |
decreases expression multiple interactions |
EXP ISO |
Propofol results in decreased expression of EDN1 protein Propofol inhibits the reaction [EDN1 protein affects the transport of Calcium] |
CTD |
PMID:9138053 PMID:17470888 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Propofol results in increased susceptibility to STA 9090] which results in decreased expression of EGFR protein |
CTD |
PMID:24784839 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ephb2 |
Eph receptor B2 |
increases expression |
ISO |
Propofol results in increased expression of EPHB2 mRNA |
CTD |
PMID:35953652 |
|
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Ewsr1 |
EWS RNA-binding protein 1 |
increases expression |
ISO |
Propofol results in increased expression of EWSR1 mRNA |
CTD |
PMID:35953652 |
|
NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544
|
|
G |
Fam95c |
family with sequence similarity 95 member C |
decreases expression |
ISO |
Propofol results in decreased expression of FAM95C mRNA |
CTD |
PMID:35238236 |
|
NCBI chr17:54,681,040...54,721,106
Ensembl chr17:54,681,044...54,720,740
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Propofol results in increased expression of FAS protein |
CTD |
PMID:21786383 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fendrr |
FOXF1 adjacent non-coding developmental regulatory RNA |
decreases expression |
ISO |
Propofol results in decreased expression of FENDRR mRNA |
CTD |
PMID:35238236 |
|
NCBI chr19:49,127,225...49,152,780
Ensembl chr19:49,121,214...49,153,240
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
Propofol results in increased expression of FN1 mRNA |
CTD |
PMID:35953652 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
EXP |
Lidocaine inhibits the reaction [Propofol results in increased expression of FOS protein] Propofol results in increased expression of FOS mRNA; Propofol results in increased expression of FOS protein |
CTD |
PMID:10781476 PMID:17136530 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions increases expression |
ISO |
FOXO1 protein affects the reaction [Propofol results in increased expression of LINC01133 mRNA] Propofol results in increased expression of FOXO1 mRNA; Propofol results in increased expression of FOXO1 protein |
CTD |
PMID:38146619 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
multiple interactions |
ISO EXP |
[Propofol co-treated with Pentobarbital] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; delta-hexachlorocyclohexane inhibits the reaction [Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol affects the reaction [Muscimol binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB1 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB3 binds to GABRG2 protein alternative form] Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; Propofol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:9316872 PMID:10049148 PMID:11399263 PMID:12939268 PMID:22029276 PMID:29038840 More...
|
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
multiple interactions |
ISO |
Propofol results in increased activity of [GABRA2 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3] |
CTD |
PMID:29038840 |
|
NCBI chr14:37,097,251...37,230,030
Ensembl chr14:37,097,279...37,228,944
|
|
G |
Gabra4 |
gamma-aminobutyric acid type A receptor subunit alpha 4 |
increases expression |
ISO |
Propofol results in increased expression of GABRA4 mRNA |
CTD |
PMID:16733821 |
|
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
|
|
G |
Gabra6 |
gamma-aminobutyric acid type A receptor subunit alpha6 |
multiple interactions |
ISO |
Propofol results in increased activity of [GABRA6 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB3 binds to GABRG2 protein alternative form] |
CTD |
PMID:29038840 |
|
NCBI chr10:26,810,411...26,825,768
Ensembl chr10:26,810,423...26,825,769
|
|
G |
Gabrb1 |
gamma-aminobutyric acid type A receptor subunit beta1 |
multiple interactions |
ISO |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB1 binds to GABRG2 protein alternative form] |
CTD |
PMID:10049148 PMID:29038840 |
|
NCBI chr14:36,068,725...36,548,946
Ensembl chr14:36,080,393...36,548,948
|
|
G |
Gabrb2 |
gamma-aminobutyric acid type A receptor subunit beta 2 |
affects response to substance multiple interactions |
EXP ISO |
GABRB2 protein affects the susceptibility to Propofol Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; Propofol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] Propofol results in increased activity of [GABRA1 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB2 binds to GABRG2 protein alternative form] |
CTD |
PMID:11399263 PMID:12939268 PMID:29038840 |
|
NCBI chr10:26,936,592...27,156,141
Ensembl chr10:26,936,551...27,151,251
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
multiple interactions |
ISO |
[Propofol co-treated with Pentobarbital] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; delta-hexachlorocyclohexane inhibits the reaction [Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol affects the reaction [Muscimol binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3]; Propofol results in increased activity of [GABRA6 protein binds to GABRB3 binds to GABRG2 protein alternative form] |
CTD |
PMID:9316872 PMID:22029276 PMID:29038840 |
|
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
|
|
G |
Gabre |
gamma-aminobutyric acid type A receptor subunit epsilon |
multiple interactions decreases response to substance |
ISO EXP |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRE]] GABRE protein results in decreased susceptibility to Propofol |
CTD |
PMID:9039914 PMID:10049148 |
|
NCBI chr X:150,060,035...150,078,773
Ensembl chr X:150,060,040...150,078,693
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
multiple interactions |
ISO EXP |
[Propofol co-treated with Pentobarbital] promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; delta-hexachlorocyclohexane inhibits the reaction [Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]]; Propofol affects the reaction [Flunitrazepam binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol affects the reaction [Muscimol binds to [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]]; Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB1 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA1 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA2 protein binds to GABRB3 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB2 binds to GABRG2 protein alternative form]; Propofol results in increased activity of [GABRA6 protein binds to GABRB3 binds to GABRG2 protein alternative form] Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Propofol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]; Propofol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:9316872 PMID:10049148 PMID:11399263 PMID:12939268 PMID:22029276 PMID:29038840 More...
|
|
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
|
|
G |
Gas5 |
growth arrest specific 5 |
increases expression |
ISO |
Propofol results in increased expression of GAS5 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gcnt4 |
glucosaminyl (N-acetyl) transferase 4 |
increases expression |
ISO |
Propofol results in increased expression of GCNT4 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 2:28,253,325...28,283,082
Ensembl chr 2:28,252,860...28,283,082
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
decreases expression |
ISO |
Propofol results in decreased expression of GLUD1 protein |
CTD |
PMID:36207479 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
decreases expression |
ISO |
Propofol results in decreased expression of GNAI2 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
increases expression multiple interactions |
ISO |
Propofol results in increased expression of GNRH1 mRNA Lipopolysaccharides promotes the reaction [Propofol results in increased expression of GNRH1 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
increases expression multiple interactions |
EXP |
Propofol results in increased expression of GRIA2 protein alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Propofol results in increased expression of GRIA2 protein] |
CTD |
PMID:28663055 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
affects response to substance |
ISO |
GRIN2A protein affects the susceptibility to Propofol |
CTD |
PMID:15731593 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
Dexmedetomidine inhibits the reaction [Propofol results in decreased phosphorylation of and results in increased activity of GSK3B protein]; Propofol results in decreased phosphorylation of and results in increased activity of GSK3B protein |
CTD |
PMID:31187143 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
decreases expression |
ISO |
Propofol results in decreased expression of H19 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of HGF mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions decreases expression |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of HIF1A mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of HIF1A protein] Propofol results in decreased expression of HIF1A protein |
CTD |
PMID:21307008 PMID:36207479 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
EXP |
Propofol results in increased expression of HMOX1 protein HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]; Propofol inhibits the reaction [Streptozocin results in decreased activity of HMOX1 protein]; Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]] |
CTD |
PMID:21468576 PMID:24810525 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hpse |
heparanase |
increases expression multiple interactions |
ISO |
Propofol results in increased expression of HPSE mRNA Lipopolysaccharides promotes the reaction [Propofol results in increased expression of HPSE mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
multiple interactions increases expression |
ISO |
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of HTATIP2 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
ISO |
Propofol results in increased expression of IGF1 mRNA |
CTD |
PMID:35953652 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igsf9b |
immunoglobulin superfamily, member 9B |
decreases expression |
ISO |
Propofol results in decreased expression of IGSF9B mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 8:25,712,644...25,769,481
Ensembl chr 8:25,712,644...25,758,554
|
|
G |
Il10 |
interleukin 10 |
increases expression |
ISO |
Propofol results in increased expression of IL10 protein |
CTD |
PMID:17032661 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
multiple interactions increases expression |
ISO |
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of IL18 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Propofol results in decreased expression of IL1B mRNA |
CTD |
PMID:35953652 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases secretion |
ISO |
Propofol results in decreased secretion of IL2RA protein |
CTD |
PMID:16119599 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
ISO |
Propofol results in decreased expression of IL6 protein Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:17032661 PMID:21307008 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
decreases phosphorylation |
ISO |
Propofol decreases phosphorylation of JAK2 protein in colon epithelium |
RGD |
PMID:32386021 |
RGD:125097524 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Propofol results in increased expression of JUN mRNA |
CTD |
PMID:10781476 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kng1 |
kininogen 1 |
multiple interactions |
ISO |
[Propofol co-treated with Pharmaceutical Vehicles] results in increased expression of KNG1 protein modified form; [Triglycerides co-treated with Propofol] results in increased expression of KNG1 protein modified form; Lidocaine inhibits the reaction [[Propofol co-treated with Pharmaceutical Vehicles] results in increased expression of KNG1 protein modified form]; nafamostat inhibits the reaction [[Propofol co-treated with Pharmaceutical Vehicles] results in increased expression of KNG1 protein modified form] |
CTD |
PMID:10655909 PMID:15983144 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Ldha |
lactate dehydrogenase A |
increases activity |
ISO |
Propofol increases activity of LDHA protein in colon epithelium |
RGD |
PMID:32386021 |
RGD:125097524 |
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lrcol1 |
leucine rich colipase-like 1 |
decreases expression |
ISO |
Propofol results in decreased expression of LRCOL1 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr12:46,326,049...46,339,475
Ensembl chr12:46,326,077...46,337,953
|
|
G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
increases expression |
ISO |
Propofol results in increased expression of LRG1 mRNA |
CTD |
PMID:21786383 |
|
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO |
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K1 protein] |
CTD |
PMID:19573522 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
ISO |
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAP2K2 protein] |
CTD |
PMID:19573522 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO EXP |
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein] Propofol results in decreased phosphorylation of MAPK1 protein PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:19573522 PMID:31257496 PMID:36207479 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO EXP |
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein] Propofol results in decreased phosphorylation of MAPK3 protein PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:19573522 PMID:31257496 PMID:36207479 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
multiple interactions increases expression |
ISO |
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MET mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mgat5 |
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase |
multiple interactions increases expression |
ISO |
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MGAT5 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr13:38,675,776...38,959,697
Ensembl chr13:38,676,119...38,959,513
|
|
G |
Mir1224 |
microRNA 1224 |
increases expression |
EXP |
Propofol results in increased expression of MIR1224 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr11:80,306,902...80,306,986
Ensembl chr11:80,306,902...80,306,986
|
|
G |
Mir146a |
microRNA 146a |
decreases expression |
EXP |
Propofol results in decreased expression of MIR146A mRNA |
CTD |
PMID:26254736 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir146b |
microRNA 146b |
decreases expression |
EXP |
Propofol results in decreased expression of MIR146B mRNA |
CTD |
PMID:26254736 |
|
NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:245,203,438...245,203,525
|
|
G |
Mir155 |
microRNA 155 |
decreases expression |
EXP |
Propofol results in decreased expression of MIR155 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir186 |
microRNA 186 |
multiple interactions |
ISO |
Propofol affects the reaction [LINC01133 affects the expression of MIR186 mRNA]; Propofol inhibits the reaction [MIR186 results in decreased expression of NR3C2 protein] |
CTD |
PMID:38146619 |
|
NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:246,582,806...246,582,891
|
|
G |
Mir221 |
microRNA 221 |
decreases expression |
EXP |
Propofol results in decreased expression of MIR221 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
|
|
G |
Mir222 |
microRNA 222 |
decreases expression |
EXP |
Propofol results in decreased expression of MIR222 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
|
|
G |
Mir27b |
microRNA 27b |
increases expression |
EXP |
Propofol results in increased expression of MIR27B mRNA |
CTD |
PMID:26254736 |
|
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
|
|
G |
Mir3473 |
microRNA 3473 |
increases expression |
EXP |
Propofol results in increased expression of MIR3473 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr13:39,499,246...39,499,312
Ensembl chr13:39,499,246...39,499,312
|
|
G |
Mir378 |
microRNA 378 |
increases expression |
EXP |
Propofol results in increased expression of MIR378 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr18:54,858,559...54,858,623
|
|
G |
Mir6215 |
microRNA 6215 |
increases expression |
EXP |
Propofol results in increased expression of MIR6215 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr 5:151,850,759...151,850,825
Ensembl chr 5:151,850,759...151,850,825
|
|
G |
Mir665 |
microRNA 665 |
increases expression |
EXP |
Propofol results in increased expression of MIR665 mRNA |
CTD |
PMID:26254736 |
|
NCBI chr 6:128,539,440...128,539,533
Ensembl chr 6:128,539,440...128,539,533
|
|
G |
Mir99a |
microRNA 99a |
increases expression |
EXP |
Propofol results in increased expression of MIR99A mRNA |
CTD |
PMID:26254736 |
|
NCBI chr11:16,200,443...16,200,523
Ensembl chr11:16,200,443...16,200,523
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
Propofol results in decreased expression of MKI67 protein |
CTD |
PMID:36207479 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of MMP2 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp24os |
MMP24 opposite strand |
decreases expression |
ISO |
Propofol results in decreased expression of MMP24OS mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 3:144,322,936...144,324,449
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
multiple interactions increases expression |
ISO |
Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MMP7 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mpc1 |
mitochondrial pyruvate carrier 1 |
decreases expression |
ISO |
Propofol results in decreased expression of MPC1 protein |
CTD |
PMID:36207479 |
|
NCBI chr 1:52,437,745...52,449,399
Ensembl chr 1:52,437,741...52,449,400
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation multiple interactions |
ISO |
Propofol results in decreased phosphorylation of MTOR protein CASC9 protein inhibits the reaction [Propofol results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:35238236 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
Propofol inhibits the reaction [Halothane results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:16965849 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
Bicuculline inhibits the reaction [Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein]]; Propofol inhibits the reaction [Vincristine results in decreased susceptibility to NGF protein] |
CTD |
PMID:11991087 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP ISO |
Propofol inhibits the reaction [Halothane results in increased expression of NOS2 protein] Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 mRNA]; Propofol inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein] |
CTD |
PMID:16965849 PMID:19573522 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]] |
CTD |
PMID:24810525 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Npy |
neuropeptide Y |
multiple interactions |
EXP |
Propofol inhibits the reaction [Potassium results in increased secretion of NPY protein] |
CTD |
PMID:29320738 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions |
ISO |
Propofol inhibits the reaction [MIR186 results in decreased expression of NR3C2 protein] |
CTD |
PMID:38146619 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nufip1 |
nuclear FMR1 interacting protein 1 |
multiple interactions affects response to substance |
EXP ISO |
NUFIP1 protein affects the reaction [Propofol results in decreased expression of BCL2 protein]; NUFIP1 protein affects the reaction [Propofol results in increased expression of BAX protein]; NUFIP1 protein affects the reaction [Propofol results in increased expression of DLG4 protein]; NUFIP1 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein] [NUFIP1 affects the susceptibility to Propofol] which affects the cleavage of CASP protein; [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BAX protein; [NUFIP1 affects the susceptibility to Propofol] which affects the expression of BCL2 protein |
CTD |
PMID:38599287 |
|
NCBI chr15:51,429,518...51,460,308
Ensembl chr15:51,429,549...51,460,310
|
|
G |
Or5ac16 |
olfactory receptor family 5 subfamily AC member 16 |
decreases expression |
ISO |
Propofol results in decreased expression of OR5AC16 mRNA |
CTD |
PMID:21786383 |
|
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[Propofol results in increased susceptibility to STA 9090] which results in increased cleavage of PARP1 protein |
CTD |
PMID:24784839 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression multiple interactions |
ISO |
Propofol results in decreased expression of PCNA protein CASC9 protein inhibits the reaction [Propofol results in decreased expression of PCNA protein] |
CTD |
PMID:35238236 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pea15 |
proliferation and apoptosis adaptor protein 15 |
decreases expression multiple interactions |
EXP |
Propofol results in decreased expression of PEA15 mRNA; Propofol results in decreased expression of PEA15 protein PEA15 protein inhibits the reaction [Propofol results in decreased expression of BCL2 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of RPS6KA3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of CREB1 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK1 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased expression of BAX protein] |
CTD |
PMID:31257496 |
|
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
|
|
G |
Pkd1l3 |
polycystin 1 like 3, transient receptor potential channel interacting |
decreases expression |
ISO |
Propofol results in decreased expression of PKD1L3 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr19:37,585,564...37,650,083
Ensembl chr19:37,585,725...37,650,155
|
|
G |
Pla2g2c |
phospholipase A2, group IIC |
increases expression |
ISO |
Propofol results in increased expression of PLA2G2C mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 5:150,959,365...150,981,388
Ensembl chr 5:150,959,182...150,981,377
|
|
G |
Pln |
phospholamban |
decreases phosphorylation |
EXP |
Propofol results in decreased phosphorylation of PLN protein |
CTD |
PMID:27495954 |
|
NCBI chr20:32,629,537...32,639,559
|
|
G |
Pnn |
pinin, desmosome associated protein |
multiple interactions decreases expression |
ISO |
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of PNN mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
EXP |
Propofol inhibits the reaction [Doxorubicin results in increased cleavage of PRKCD protein] |
CTD |
PMID:22015447 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prl |
prolactin |
increases secretion |
ISO |
Propofol results in increased secretion of PRL protein |
CTD |
PMID:18482853 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Pten |
phosphatase and tensin homolog |
increases expression multiple interactions |
ISO |
Propofol results in increased expression of PTEN protein CASC9 protein inhibits the reaction [Propofol results in increased expression of PTEN protein] |
CTD |
PMID:35238236 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
Propofol inhibits the reaction [lipoteichoic acid results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:19573522 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Ren |
renin |
multiple interactions |
ISO |
[Propofol co-treated with desflurane] results in increased expression of REN protein |
CTD |
PMID:8017643 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rnu12 |
RNA, U12 small nuclear |
decreases expression |
ISO |
Propofol results in decreased expression of RNU12 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 7:114,303,546...114,303,696
Ensembl chr 7:114,303,546...114,303,696
|
|
G |
Rorb |
RAR-related orphan receptor B |
multiple interactions decreases expression |
ISO |
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of RORB mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 1:216,363,629...216,544,390
Ensembl chr 1:216,363,629...216,544,390
|
|
G |
Rps6ka3 |
ribosomal protein S6 kinase A3 |
decreases expression multiple interactions |
EXP |
Propofol results in decreased expression of RPS6KA3 protein PEA15 protein inhibits the reaction [Propofol results in decreased expression of RPS6KA3 protein] |
CTD |
PMID:31257496 |
|
NCBI chr X:35,517,306...35,623,296
Ensembl chr X:35,517,306...35,623,207
|
|
G |
Rpsa |
ribosomal protein SA |
increases expression multiple interactions |
ISO |
Propofol results in increased expression of RPSA mRNA Lipopolysaccharides promotes the reaction [Propofol results in increased expression of RPSA mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
|
|
G |
Ryr2 |
ryanodine receptor 2 |
decreases phosphorylation |
EXP |
Propofol results in decreased phosphorylation of RYR2 protein |
CTD |
PMID:27495954 |
|
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
|
|
G |
Serpinf1 |
serpin family F member 1 |
increases expression |
ISO |
Propofol results in increased expression of SERPINF1 protein |
CTD |
PMID:36207479 |
|
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Set |
Set nuclear proto-oncogene |
decreases expression multiple interactions |
ISO |
Propofol results in decreased expression of SET mRNA Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of SET mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Slc1a1 |
solute carrier family 1 member 1 |
multiple interactions |
EXP |
[Tetradecanoylphorbol Acetate co-treated with Propofol] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of SLC1A1 protein] |
CTD |
PMID:17382927 |
|
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
decreases expression |
ISO |
Propofol results in decreased expression of SLC2A1 protein |
CTD |
PMID:36207479 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc38a3 |
solute carrier family 38, member 3 |
decreases expression |
ISO |
Propofol results in decreased expression of SLC38A3 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 8:108,323,889...108,339,959
Ensembl chr 8:108,323,894...108,339,988
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
decreases expression |
ISO |
Propofol results in decreased expression of SLC6A3 protein |
CTD |
PMID:32612007 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression multiple interactions |
EXP |
Propofol results in decreased expression of SLC7A11 protein alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Propofol results in decreased expression of SLC7A11 protein] |
CTD |
PMID:28663055 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions decreases expression |
ISO |
Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of SMAD2 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Snap25 |
synaptosome associated protein 25 |
multiple interactions |
EXP |
SNAP25 protein affects the reaction [Propofol affects the localization of STX1A protein] |
CTD |
PMID:29320738 |
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
Propofol inhibits the reaction [Doxorubicin results in decreased expression of SOD1 protein] |
CTD |
PMID:22015447 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression multiple interactions |
EXP |
Propofol results in increased expression of SOD2 protein Propofol inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein] |
CTD |
PMID:21468576 PMID:22015447 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases expression |
ISO |
Propofol results in increased expression of SRC mRNA |
CTD |
PMID:35953652 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases expression |
ISO |
Propofol results in decreased expression of SRD5A2 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions increases phosphorylation decreases phosphorylation |
EXP ISO |
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]; Propofol promotes the reaction [Streptozocin results in decreased phosphorylation of STAT3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of NPPA mRNA]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]] Propofol results in increased phosphorylation of STAT3 protein Propofol decreases phosphorylation of STAT3 protein in colon epithelium |
CTD RGD |
PMID:24810525 PMID:32386021 |
RGD:125097524 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stx1a |
syntaxin 1A |
multiple interactions affects localization |
EXP |
Propofol inhibits the reaction [barium chloride affects the localization of STX1A protein]; SNAP25 protein affects the reaction [Propofol affects the localization of STX1A protein]; STX1A protein modified form inhibits the reaction [Propofol affects the localization of STX1A protein]; STX1A protein modified form inhibits the reaction [Propofol inhibits the reaction [barium chloride affects the localization of STX1A protein]] |
CTD |
PMID:29320738 |
|
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
|
|
G |
Tdh |
L-threonine dehydrogenase |
decreases expression |
ISO |
Propofol results in decreased expression of TDH mRNA |
CTD |
PMID:21786383 |
|
NCBI chr15:37,739,823...37,753,365
Ensembl chr15:37,739,823...37,753,365
|
|
G |
Th |
tyrosine hydroxylase |
decreases expression |
ISO |
Propofol results in decreased expression of TH protein |
CTD |
PMID:32612007 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression multiple interactions |
ISO |
Propofol results in increased expression of TIMP2 mRNA; Propofol results in increased expression of TIMP2 protein Lipopolysaccharides promotes the reaction [Propofol results in increased expression of TIMP2 mRNA] |
CTD |
PMID:35953652 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tincr |
TINCR ubiquitin domain containing |
increases expression |
ISO |
Propofol results in increased expression of TINCR mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 9:1,387,105...1,389,337
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]; TLR4 protein affects the reaction [Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] |
CTD |
PMID:19433076 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tmc6 |
transmembrane channel like 6 |
increases expression |
ISO |
Propofol results in increased expression of TMC6 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr10:102,982,059...102,999,509
Ensembl chr10:102,971,229...102,998,960
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; TLR4 protein affects the reaction [Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] |
CTD |
PMID:19433076 PMID:21307008 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
EXP ISO |
Propofol inhibits the reaction [Doxorubicin results in increased expression of TP53 protein] Propofol results in increased expression of TP53 protein |
CTD |
PMID:22015447 PMID:28804952 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
decreases expression multiple interactions |
EXP |
Propofol results in decreased expression of TRPC6 protein 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole promotes the reaction [Propofol results in decreased expression of TRPC6 protein]; hyperforin inhibits the reaction [Propofol results in decreased expression of TRPC6 protein] |
CTD |
PMID:36640868 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of Propofol |
CTD |
PMID:15502008 |
|
NCBI chr 9:88,739,577...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
decreases activity affects metabolic processing increases glucuronidation multiple interactions |
ISO |
Propofol results in decreased activity of UGT1A9 protein UGT1A9 protein affects the metabolism of Propofol UGT1A9 protein results in increased glucuronidation of Propofol [Warfarin binds to and affects the activity of UGT1A9 protein] which affects the glucuronidation of Propofol; licochalcone A inhibits the reaction [UGT1A9 protein results in increased glucuronidation of Propofol]; shikonin inhibits the reaction [UGT1A9 protein results in increased glucuronidation of Propofol]; Warfarin affects the reaction [UGT1A9 protein results in increased glucuronidation of Propofol] |
CTD |
PMID:12756209 PMID:14570768 PMID:15286053 PMID:15378558 PMID:15769885 PMID:15988124 PMID:18816295 PMID:25393417 PMID:26875642 PMID:31128210 More...
|
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
increases expression |
ISO |
Propofol results in increased expression of UHRF1 mRNA |
CTD |
PMID:35238236 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
Propofol affects the reaction [LINC01133 affects the expression of VIM protein] |
CTD |
PMID:38146619 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xist |
X inactive specific transcript |
increases expression |
ISO |
Propofol results in increased expression of XIST mRNA |
CTD |
PMID:35238236 |
|
NCBI chr X:68,474,987...68,492,500
|
|